Kraig Biocraft Laboratories, Inc. (KBLB), a biotechnology company, has their focus on developing high performance polymers and technical fibers. The company is utilizing their proprietary genetic engineering technology to develop and produce polymers and protein-based materials, including Spider silk, which may have numerous commercial and consumer applications.

Kraig Biocraft is working with university scientists and laboratories to create these new polymers that have potentially broad applications in the multi-billion dollar marketplace for high performance polymers. The company sponsors and collaborates on research projects within university genetic engineering laboratories as a means of utilizing the greatest minds in their field.

Spider Silk is one of the strongest fibers produced in nature. The spider’s repelling silk is of particular commercial interest since it is both extremely strong and extremely flexible. Although exciting commercial opportunities exist for the natural polymer, there is no known way to produce the fibers in commercial quantity. KraigLabs, in cooperation with two leading universities, has acquired proprietary genetic engineering technology to unlock the mystery.

CEO Kim Thompson leads the company with formal education in the fields of economics and law. With interest in genetic engineering dating back to the 1970s, Mr. Thompson has invented a pending provisional patent application for a number of organic polymers. This patent application has been assigned to benefit Kraig Biocraft and is a central part of the company’s efforts in bringing those inventions to the market.

Earlier this month, Kraig Biocraft Laboratories announced that its scientific team, including Dr. Malcolm Fraser, Dr. Wang, Dr. Sohn, and other members, have found a process capable of doubling the number of gene transfers performed, greatly increasing productivity of the spider silk and high performance polymer development program.

Kraig Biocraft is focused on developing and commercializing high performance polymers using spider silk gene sequences. The company intends to participate in the $92 billion market for high performance and technical fibers. Last year, Kraig Biocraft Laboratories signed an intellectual property and collaborative research agreement with the University of Notre Dame and has since then been a proud sponsor of scientific research within the university.

CEO Kim K. Thompson commented, “Until recently, we were performing approximately 200 to 400 micro-injections for DNA transfer on a weekly basis. With the huge increase in brain-power that resulted from the University of Notre Dame’s addition of Dr. Wang, Dr. Sohn and other scientists to the team, we have seen a dramatic increase in both the quality and quantity of the work performed. Significantly, we are currently performing approximately 1,000 gene transfers in a single week. That puts us well ahead of our development target. Every gene transfer performed has the potential to result in the development of a new polymer or high performance fiber.”

“The new research team is proceeding in a systematic fashion to optimize the procedures to generate a good number of transgenic,” said Dr. Fraser, a member of Kraig’s Scientific Advisory Board and the head of the University of Notre Dame laboratory where the gene insertions are taking place. “Based upon what I see happening in the laboratory and with this team of scientists, I have every expectation that this is going to be a very good year,” Dr. Fraser added.

“This heightened pace,” interjected Thompson, “has been accompanied by a reformulation of the DNA inserts. The increase in productivity has been so great that instead of using a single DNA construct, we are now using multiple constructs. This is a very exciting time for the research team and Kraig.”

A couple months ago, genetic engineer Dr. Bong-Hee Sohn joined Kraig Biocraft’s research and development team to develop new high performance polymers using spider silk gene sequences. Dr. Sohn earned her Ph.D. from Kyung-Hee Univ. in South Korea and has extensive research background. One of her areas of expertise in genetic engineering is the development of innovative methods for transgenic silkworm production.

CEO Kim K. Thompson stated, “Dr. Sohn has already made a significant impact on the pace and direction of our development program. This is a very exciting time for the Company and for the research laboratory. The University of Notre Dame hired Dr. Sohn to work on specific applications of genetic engineering in silkworm for polymer development and protein expression platform technologies, which are the Company’s major areas of focus.”

She continued, “We would like to express our congratulations to the research team for their foresight in initiating this addition and expansion. The Company is now fully on target for significantly accelerating the pace of its R & D.”

Kraig Biocraft has focused their efforts on developing and commercializing high performance polymers using spider silk gene sequences. The company intends to tap into the $92 billion market for high performance and technical fibers. Kraig Biocraft believes that spider silk is a “super fiber” that will have numerous commercial and consumer applications.

Kraig Biocraft Laboratories, Inc. (KBLB.OB) is Led by a Knowledgeable Board of Scientific Advisors

Malcolm. J. Fraser, Jr. Ph.D. earned his Ph.D from Ohio State University and performed postdoctoral research at Penn State University and Texas A&M University. At the Texan University, he played a key role in developing the genetic expression system which is now a widely used methodology for producing organic molecules, including pharmaceuticals, on an industrial scale.

Randy Lewis, Ph.D received his B.S. in chemistry from the California Institute of Technology, and his M.S. in chemistry and Ph.D. in Biochemistry from the University of California, San Diego. Dr. Lewis, internationally renowned for his work on spider silk, is the named inventor of a number of patents relating to spider silk polymers. He currently heads the Lewis Laboratory within the Department of Molecular Biology at the University of Wyoming. The study of spider silk polymers and their underlying genetics is a major focus of Dr. Lewis’s research.

Donald L. Jarvis, Ph.D. earned both his B.S. and M.S. in microbiology at Idaho State University, and received his Ph.D. in Virology at Baylor College of Medicine. In 1987 he undertook postdoctoral studies on glycoprotein biosynthesis at Texas A&M, and within two years Dr. Jarvis moved into an independent position at Texas A&M. Currently, Dr. Jarvis heads a research laboratory within the University’s Department of Molecular Biology which focuses on biochemistry, biosynthesis, and practical genetic engineering applications. He is the author or co-author of many scientific articles in the fields of biosynthesis, genetic engineering and biochemistry.

The Black Chandelier’s uniqueness and exclusivity draws crowds away from big box retailers. Crazy models like Lisa D’Amato, eco-friendly fabrics, in-house sewers and silk screeners, and manufacturing relationships with top-notch Asian companies are just a few unique features that set Black Chandelier apart from clothing giants such as The Gap, Hot Topic, and Target.

Black Chandelier currently operates one retail location in the high-end shopping complex of The Gateway in downtown Salt Lake. The retail store was designed to be as much of a tourist attraction as an innovative retail shopping experience, and is filled the abstract and fantastical clothing designs of co-founder Jared Gold.

Black Chandelier also operates an online store that offers many of the same merchandise that can be found in the retail location, but also includes more information on Jared Gold, Black Chandelier’s various Runway events, and more. To view a commercial of Black Chandelier and see the merchandise for yourself, visit http://www.nexiaholdings.com/video/BCcommercial1.html

Kraig Biocraft Laboratories, Inc. (KBLB.OB) is Backed by a Team of Professionals who Believe in the Company’s Potential

Kraig Biocraft Laboratories, Inc. was founded by the current CEO Kim Thompson, who invented the company’s technology. Kraig Biocraft is a fully reporting organization and trades on the over-the-counter market under the stock symbol KBLB. Currently, there are about 50 million common shares outstanding, approximately 64% of which is being held by Mr. Thompson.

At Kraft Biocraft, Mr. Thompson functions as the overall coordinator for the company’s business operations, ongoing research and development. Several prominent genetic scientists, one at the University of Wyoming and another at the University of Notre Dame, have teamed up with the company to further develop its technologies. The laboratory staffs of these professors are also greatly contributing to the company’s efforts.

The University of Wyoming Foundation has contributed significant intellectual property to Kraft Biocraft and has a major shareholder stake in the company. A number of the major discoveries from these associated researchers have proven essential to the company’s product development efforts. According to a comprehensive report prepared by Emerging Growth Research, the company has acquired exclusive rights to university owned technologies and is able to use these rights in product development and commercialization.

The company defines its technology as a unique protein expression system that is potentially highly scalable and cost-effective in producing a variety of different proteins that can be marketed into the pharmaceutical, technical textiles and materials markets. This unique protein expression system, known as spider silk, is one of the strongest and most resilient fibers known to man.

Kraig Biocraft Laboratories is a biotechnology company primarily focused on pursuing a unique protein expression system with the objective of producing the next generation of technical fibers. The company is utilizing state of the art genetic techniques in order to develop a transgenic silkworm capable of producing commercially viable amounts of spider silk.

Spider silk is known as one of the strongest fibers found in nature. The fiber is extremely elastic and resilient and has several properties that are unmatched by even the most exotic of man-made fibers. Spider silk has an unparalleled ability to absorb energy and dissipate it in a very controlled manner, making it especially attractive for applications where energy absorption is a key design factor.

One of spider silk’s most significant properties is its extreme resistance to breaking under strain. This characteristic makes spider silk particularly appealing for use as a “super fiber.” Pound for pound, spider silk is much stronger than steel with clear evidence of spider silk being at least five times stronger than steel of the same diameter.

There is little debate whether spider silk is superior over many other man-made and natural fibers for certain applications, however the issue is how to cost effectively produce spider silk in sufficient quantities. With Kraig Biocraft’s leading team of scientific experts and breakthroughs taking place in the lab, the world is closer than ever to experiencing the many benefits offered by this exciting technology.

Kraig Biocraft Laboratories, Inc. has focused their efforts on developing significant high-performance technical fibers and polymers utilizing their research related to spider genes to create a transgenic variety of silkworms capable of spinning a new “super fiber” that is either similar or an exact copy of natural spider silk, which is known as one of the strongest and most resilient fibers. For many years the textile and material science industries have tried to replicate spider silk, but have not been successful.

The company has acquired the exclusive rights, in their field of use, to the genetic sequences patented by the University of Wyoming and the genetic engineering technology developed by the University of Notre Dame. The company’s intellectual property portfolio also includes a separate US provisional patent application regarding certain methodologies, genetic sequences, organic polymers and composites of fibers.

Although the production of a “super fiber” is the primary focus at this time, Kraig Biocraft is also considering the production of other unique proteins utilizing transgenic silk worms as a protein expression platform. It is believe that there is a large viable market for these unique proteins within the pharmaceutical, biotechnology and other research driven industries.

Kraig Biocraft Laboratories, Inc. is participating in a market that is generally referred to as the “technical textiles” market. This market encompasses a wide range of products used for numerous applications. The specific sub-sectors the company is targeting can be broken down into two main areas: aramid fibers and ultra-high molecular weight polyethylene fibers.

The worldwide market for these fibers and other high performance technical fibers is currently estimated at approximately $90 billion per year, with the United States accounting for 50%+ of the market. According to a research report completed by Emerging Growth Research, the market has experienced significant growth over the past 10 years and is expected to continue to perform at a robust growth rate over the coming years.

While there are already man-made products well established in the marketplace, Kraig Biocraft’s spider silk contains certain properties that are superior to these synthetically derived products. For example, although Kevlar can be measured to have greater tensile strength versus spider silk on a pound per pound basis, the product pales in comparison to spider silk’s ability to absorb energy prior to fiber breakage. Additionally, products made using spider silk could be completely biodegradable, a feature that has been purposely engineered out of competing high-performance fiber products.

Emerging Growth Research, LLP recently completed a 25 page research report on Kraig Biocraft Laboratories, Inc. and its Spider Silk technology. To establish a value for the “super fiber,” the research bureau evaluated the success of DuPont’s Kevlar, which currently brings in more than $5 billion a year from sales of Kevlar. After the evaluation, Emerging Growth Research concluded that Kevlar is worth approximately $8 billion.

If Kraig Biocraft makes a substantial breakthrough in the laboratory and is able to further refine its technology to produce commercial amounts, the technology will be immediately worth potentially several hundred million dollars to one of the multinational corporations operating within the technical textiles industry. Recognizing the massive potential, Emerging Growth Research has established a $4.00 target price, which represents a market capitalization of $200 million.

In final remarks, the research bureau stated, “Should additional refinements be made and actual production of fibers commence resulting in the beginnings of a robust fast growing market for spider silk-based products, we believe the value of this technology could potentially skyrocket, ultimately being worth billions of dollars to the company’s investors. Shares of Kraig Biocraft Laboratories are clearly speculative, but offer some exciting appreciation possibilities in the future. It will surely be exciting to watch developments at this company over the coming years.

Kraig Biocraft excitedly announced today that the scientific team has achieved the activation of fluorescent marker gene sequences that were incorporated into spider silk DNA packets by the researchers. The team has successfully inserted the DNA packets into silkworms, which are now visibly emitting florescence.

CEO Kim K. Thompson commented, “The fact that we are now seeing fluorescence in the modified silkworms establishes that the DNA insertion packets are working and that we have succeeded in obtaining chromosomal insertion and expression. In other words, not only are the DNA packets incorporating themselves into the silkworm chromosome as expected, the silkworms are actually producing the fluorescent proteins as they are instructed to do by the genetic coding in the spider silk insertion packets.”

The DNA packets contain the genetic instructions for the production of new spider silk based fibers and textiles. The florescent marker sequences, which are included in the packets, instruct the silkworm to produce florescent proteins. Because the silkworm is producing florescent proteins, the scientists know that they have succeeded in altering its DNA, because silkworms do not naturally produce florescent proteins.

This achievement is a huge step forward for Kraig Labs. The fact that these proteins are markers establishes that the DNA packets have been successfully transferred. “The atmosphere here is one of tremendous excitement,” said Thompson.

“Another generation will be required in order to test whether we have achieved a germ line stable transgenic,” continued Mr. Thompson. “The team will be able to test the next generation for the florescent makers within the ten days. From then on, we should have a new generation of silkworms ready for testing at regular intervals of approximately fourteen days. This is a dramatic shift forward in the Company’s spider silk and high performance polymer development program.”

Kim Thompson, CEO of Kraig Biocraft, was recently featured by Small Cap Voice in an exclusive audio interview. During the interview, Mr. Thompson described the company’s business and targeted market, advantages of spider silk, gave background on his previous accomplishments, commented on the bright minds working within the company, provided his vision for the next 5-10 years, and much more.

New Research Report Features Kraig Biocraft Laboratories, Inc. (KBLB.OB)

Today, Kraig Biocraft Laboratories, Inc. announced that a new research report featuring the company has been published by Emerging Growth Research, LLP. The comprehensive report provides an overview of the company as well as updates investors on recent activities.

Kim K. Thompson, CEO of Kraig Biocraft commented, “We have been making significant progress in the laboratory toward the aim of producing new spider silk based fibers and textiles. We recently announced the scientific team successfully achieved the activation of florescent gene marker sequences, which the researchers incorporated into spider silk DNA packets. This was a major milestone for the Company. The new and updated research report provides an excellent overview of the methodologies we are employing to address this potentially lucrative market.”

While naturally produced spider silk has long been understood to have a superior level of tensile strength, research institutions and companies alike are seemingly on the verge of attaining the ability to harness this technology and apply it to various fields of endeavor. Sure, the idea of using such spider silk to swing from one building to another might be attractive to a certain comic book superhero fan club. In reality, however, the utility of this “packaged spider silk” could virtually spread across multiple, disparate applications in both governmental and commercial sectors. This concept of application versatility truly showcases this technology’s remarkable value for growth in the not-so-distant future.

Take Velcro back in the 1940’s, for example. This “zipperless zipper” idea came to a Swiss engineer named George de Mestra after witnessing seeds continually latching onto his clothes and his dog’s fur. In time, NASA was using it onboard their shuttles in both astronaut spacesuits and on-the-wall supply fasteners. After soon being incorporated in an array of leisure applications including skiing, surfing, and SCUBA, it further became utilized in nuclear power plants, automobiles, army tanks, combat uniforms, and footwear.

A packaged spider silk product would represent the same universal applicability as Velcro, thereby covering a vast array of commercialization areas. In terms of government utility, this spider silk can be used in ballistic armor and cables on board aircraft carriers. In terms of health-based utility, this material can be used in the creation of artificial ligaments or tendons as well as in the improvement of bandages and surgical thread. Further utility is foreseeable in the production of a number of commercial applications including lightweight clothing, fishing lines, seat belts, high strength cables, parachutes, biodegradable bottles, just to name a few.

Qualitystocks has identified the major players in this emerging industry which includes smaller companies represented by Kraig Biocraft Laboratories Inc (KBLB.OB), Angiotech International, Nexia Biotechnologies, and Oxford Biomaterials as well as the chemical giant, Dupont. Government organizations, consisting of the US Army, US Air Force, and the National Science Foundation, have also been actively funding spider silk research programs including Tufts University, Massachusetts Institute of Technology, and the University of California at Santa Barbara.

When the laser first came out, there were only a handful of things anybody could figure out what to do with it. Now it's everywhere. Kraig's developments in the area of genetic engineering and materials science could be a quantum leap, for which it's almost impossible to determine the long term potential.

Today, QualityStocks published a 6 minute interview featuring Kraig Biocraft CEO Kim Thompson. In the interview, Mr. Thompson commented on the business, the spider silk technology it is developing, the enormous market for spider silk, how the company has progressed, the milestones the management has set for this year as well as provided a synopsis of the company’s scientific team members.